Position in VRTX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$119,700,405
-$5,825,005 QoQ
Shares Held
268,062
-3.2% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 25.954443375040103.ToString("F0")%
Shared 0.ToString("F0")%
None 74.0455566249599.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2025CallValue
$242,410
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $464,981,245 across 201 Biotechnology names. VRTX ranks #1 (25.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
268,062 | $119,700,405 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63,987 | $49,438,915 | |
| 3 | INSM |
INSMED Inc
|
138,281 | $22,611,709 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67,637 | $22,379,054 | |
| 5 | EXEL |
Exelixis, Inc.
|
399,612 | $17,139,358 | |
| 6 | ARGX |
Argenx SE
|
23,247 | $16,976,121 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
194,304 | $12,557,867 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
378,656 | $10,488,771 |
All Filings in VRTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $119,700,405 | 268,062 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $125,525,410 | 276,878 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $103,464,238 | 264,182 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $107,122,243 | 240,616 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $242,410 | 500 | Call | Sole | 2025-05-07 | |
| 2025-03-31 | $105,178,790 | 216,944 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $76,937,043 | 191,053 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $88,231,722 | 189,713 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $98,355,736 | 209,839 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $76,650,911 | 183,371 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,220,670 | 3,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $66,581,852 | 163,636 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $60,415,304 | 173,737 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $60,538,373 | 172,028 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $52,774,225 | 167,500 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $47,746,596 | 165,339 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $38,530,535 | 133,075 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $38,271,590 | 135,816 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $35,623,448 | 136,504 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $26,462,239 | 120,502 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,421,430 | 112,583 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,820,208 | 73,502 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $13,630,687 | 63,431 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,090,772 | 42,696 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $12,222,269 | 44,915 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $12,800,348 | 44,092 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $9,572,252 | 40,228 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||